All lobbying filings

TIBER CREEK GROUP

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF GENENTECH, INC.) · Government relations.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 19, 2025

Official filing document

Bills named in this filing 2

S 1041
Affordable Prescriptions for Patients Act
S 1096
Preserve Access to Affordable Generics and Biosimilars Act

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare Part B Pricing Reform.

Health Issues

Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).

Issues related to intellectual property; Issues related to S.1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.